Grossmann R, Babin-Ebell J, Misoph M, Schwender S, Neukam K, Hickethier T, Elert O, Keller F
Central Laboratory, University Medical Centre, Würzburg, Germany.
Heart Vessels. 1996;11(6):310-7. doi: 10.1007/BF01747190.
During cardiopulmonary bypass (CPB) mechanical stress and the contact of blood with artificial surfaces lead to the activation of pro- and anticoagulant systems and the complement cascade, and to changes in cellular components. This phenomenon causes the "postperfusion-syndrome", with leukocytosis, increased capillary permeability, accumulation of interstitial fluid, and organ dysfunction. In this study, we focused on the influence of the extracorporeal circulation, sternotomy, and heparin administration on the activation of coagulation and fibrinolysis. In 15 patients we investigated coagulation parameters before, during and post CPB, i.e., fibrinogen, antithrombin (AT) III, thrombin-antithrombin complex (TAT), prothrombin fragments F1 + 2 (F1 + 2), factor (F) XIIa, tissue factor (TF), and parameters of the fibrinolytic system, i.e., plasmin-antiplasmin-complex (PAP), D-dimer, tissue-plasminogen-activator (tPA), urokinase-type plasminogen activator (uPA), and plasminogen-activator inhibitor type 1 (PAI 1). The results demonstrate distinct alterations in the above mentioned parameters. Despite administration of a high dose of heparin (activated clotting time [ACT] > 450s) combined with a low dose of aprotinin, activation of the coagulation and fibrinolytic pathways was observed. We found this activation was mainly caused by CPB and not by sternotomy. The activation of coagulation was due to foreign surface contact (F XII => F XIIa) as well as to an effect of tissue factor release in the late phase of CPB. The enhanced fibrinolytic activity during CPB was, at least in part, caused by tPA and was followed by PAI 1 release.
在体外循环(CPB)期间,机械应力以及血液与人工表面的接触会导致促凝血和抗凝系统以及补体级联反应的激活,并引起细胞成分的变化。这种现象会导致“灌注后综合征”,表现为白细胞增多、毛细血管通透性增加、间质液积聚和器官功能障碍。在本研究中,我们重点关注体外循环、胸骨切开术和肝素给药对凝血和纤维蛋白溶解激活的影响。我们对15例患者在CPB前、期间和之后进行了凝血参数的研究,即纤维蛋白原、抗凝血酶(AT)III、凝血酶 - 抗凝血酶复合物(TAT)、凝血酶原片段F1 + 2(F1 + 2)、因子(F)XIIa、组织因子(TF),以及纤维蛋白溶解系统的参数,即纤溶酶 - 抗纤溶酶复合物(PAP)、D - 二聚体、组织纤溶酶原激活物(tPA)、尿激酶型纤溶酶原激活物(uPA)和纤溶酶原激活物抑制剂1型(PAI 1)。结果表明上述参数有明显变化。尽管给予了高剂量肝素(活化凝血时间[ACT] > 450秒)并联合低剂量抑肽酶,但仍观察到凝血和纤维蛋白溶解途径的激活。我们发现这种激活主要是由CPB引起的,而非胸骨切开术。凝血的激活是由于异物表面接触(F XII => F XIIa)以及CPB后期组织因子释放的作用。CPB期间增强的纤维蛋白溶解活性至少部分是由tPA引起的,随后是PAI 1的释放。